Arbutus Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
CEOLindsay Androski
CEOLindsay Androski
Employees44
Employees44
HeadquartersWarminster, Pennsylvania
HeadquartersWarminster, Pennsylvania
Founded2005
Founded2005
Employees44
Employees44
ABUS Key Statistics
Market cap966.31M
Market cap966.31M
Price-Earnings ratio-21.37
Price-Earnings ratio-21.37
Dividend yield—
Dividend yield—
Average volume1.35M
Average volume1.35M
High today$4.86
High today$4.86
Low today$4.68
Low today$4.68
Open price$4.70
Open price$4.70
Volume710.88K
Volume710.88K
52 Week high$5.10
52 Week high$5.10
52 Week low$2.71
52 Week low$2.71
Stock Snapshot
The current Arbutus Biopharma(ABUS) stock price is $4.78, with a market capitalization of 966.31M. The stock trades at a price-to-earnings (P/E) ratio of -21.37.
As of 2026-01-14, Arbutus Biopharma(ABUS) stock has fluctuated between $4.68 and $4.86. The current price stands at $4.78, placing the stock +2.1% above today's low and -1.6% off the high.
The Arbutus Biopharma(ABUS)'s current trading volume is 710.88K, compared to an average daily volume of 1.35M.
During the past year, Arbutus Biopharma(ABUS) stock moved between $2.71 at its lowest and $5.10 at its peak.
During the past year, Arbutus Biopharma(ABUS) stock moved between $2.71 at its lowest and $5.10 at its peak.
People also own
Based on the portfolios of people who own ABUS. This list is generated using Robinhood data, and it’s not a recommendation.